Mar. 13, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small ...
The stock has a 50-day moving average of $21.80 and a 200-day moving average of $23.88. Enliven Therapeutics has a one year low of $10.90 and a one year high of $30.03. The stock has a market cap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback